38661357|t|Correlation between APOE4 gene and gut microbiota in Alzheimer's disease.
38661357|a|Gut microbiota (GM) dysbiosis has been increasingly associated with Alzheimer's disease (AD). However, the association between APOE4, the most common genetic risk factor for sporadic AD, and GM in AD remains unclear. In this study, we conducted a comparative analysis of the GM of participants from China and the USA, with and without APOE4 genes and with or without AD (67 AD cases, 67 control cases). Our results revealed that the GM alpha diversity was not different between groups (AD_APOE4, Control_APOE4, AD_non-APOE4, and Control_non-APOE4) (419.031 +- 143.631 vs 391.091 +- 126.081, 351.086 +- 169.174 and 386.089 +- 177.200, respectively. P > 0.05). Interestingly, individuals in the AD_APOE4 group had different bacterial compositions and bacterial biomarkers. The Kruskal-Wallis rank sum test indicated that the abundances of many bacterial species in the AD_APOE4 patients differed from those in control individuals, including decreases in unclassified_g__Escherichia-Shigella (1.763 +- 6.73, 4.429 +- 11.13, 8.245 +- 16.55, and 5.69 +- 13.91 in four groups, respectively; P < 0.05), and unclassified_g_Clostridium_sensu_stricto_1 (0.1519 +- 0.348, 2.502 +- 5.913, 0.5146 +- 0.9487, 1.063 +- 3.428 in four groups, respectively; P < 0.05), and increases in gut_metagenome_g_Faecalibacterium (2.885 +- 4.47, 2.174 +- 3.957, 0.5765 +- 1.784, 1.582 +- 2.92 in four groups, respectively. P < 0.01) and unclassified_g_Bacteroides (3.875 +- 3.738, 2.47 +- 2.748, 2.046 +- 3.674, 3.206 +- 3.446 in four groups, respectively; P < 0.05). In the KEGG pathway level 2 analysis, we identified three significant differences in relative abundances of predicted functions between AD_APOE4 and AD_non-APOE4_carrier groups: neurodegenerative diseases (0.0007 +- 0.0005 vs 0.0009 +- 0.0004; P < 0.01), metabolism (0.0240 +- 0.0003 vs 0.0250 +- 0.0003; P < 0.05), and biosynthesis of other secondary metabolites (0.0094 +- 0.0002 vs 0.0090 +- 0.0002; P < 0.05). Receiver operating characteristic curves further demonstrated an area under the curve (AUC) of 0.74 for the discrimination of AD_APOE4_carrier and AD_non-APOE4_carrier individuals.
38661357	20	25	APOE4	Gene	348
38661357	53	72	Alzheimer's disease	Disease	MESH:D000544
38661357	142	161	Alzheimer's disease	Disease	MESH:D000544
38661357	163	165	AD	Disease	MESH:D000544
38661357	201	206	APOE4	Gene	348
38661357	257	259	AD	Disease	MESH:D000544
38661357	271	273	AD	Disease	MESH:D000544
38661357	409	414	APOE4	Gene	348
38661357	441	443	AD	Disease	MESH:D000544
38661357	448	450	AD	Disease	MESH:D000544
38661357	560	562	AD	Disease	MESH:D000544
38661357	563	568	APOE4	Gene	348
38661357	578	583	APOE4	Gene	348
38661357	585	587	AD	Disease	MESH:D000544
38661357	592	597	APOE4	Gene	348
38661357	615	620	APOE4	Gene	348
38661357	767	769	AD	Disease	MESH:D000544
38661357	770	775	APOE4	Gene	348
38661357	941	943	AD	Disease	MESH:D000544
38661357	944	949	APOE4	Gene	348
38661357	950	958	patients	Species	9606
38661357	1359	1375	Faecalibacterium	Species	216851
38661357	1750	1752	AD	Disease	MESH:D000544
38661357	1753	1758	APOE4	Gene	348
38661357	1763	1765	AD	Disease	MESH:D000544
38661357	1770	1775	APOE4	Gene	348
38661357	1792	1818	neurodegenerative diseases	Disease	MESH:D019636
38661357	2154	2156	AD	Disease	MESH:D000544
38661357	2157	2162	APOE4	Gene	348
38661357	2175	2177	AD	Disease	MESH:D000544
38661357	2182	2187	APOE4	Gene	348
38661357	Association	MESH:D019636	348
38661357	Association	MESH:D000544	348

